CHART 1. Structures of Selected Polyoxins and
Nikkomycins
Application of the Ugi Reaction for the One-Pot
Synthesis of Uracil Polyoxin C Analogues
Andrew Plant,*,† Peter Thompson,‡ and David M. Williams*
Centre for Chemical Biology, Richard Roberts Building,
Department of Chemistry, UniVersity of Sheffield,
Sheffield S3 7HF, U.K., and Research Chemistry, Syngenta,
Jealott’s Hill International Research Centre,
Bracknell, Berkshire RG42 6EY, U.K.
d.m.williams@sheffield.ac.uk; andrew.plant@syngenta.com
ReceiVed February 3, 2009
requirements for biological activity. These include the pyrimi-
dine base,2,3 the C5′ carboxyl group and associated C5′-(S)-config-
uration4-7 and the presence of a free NH on the amide backbone
of the side chain.8,9
One of the simplest reported routes to uracil polyoxin C
(UPOC) analogues involves a modified Strecker reaction
between 2′,3′-isopropylidene-protected uridine-5′-aldehyde (1),
an amino acid, and TMSCN in the presence a Lewis acid.10
This affords UPOC precursors, 5′-R-amino nucleosides, in
reasonable yield, but as a mixture of two diastereoisomers with
ratios of between 6.5:1 and 4:1 in favor of the natural (C5′-S)
configuration of UPOC. Stereoselective synthetic routes to
polyoxin C and analogues thereof have also been described by
a number of groups, including ourselves.10-18
A simple, two-step synthesis of amide derivatives of uracil
polyoxin C (UPOC) methyl ester using the Ugi reaction is
described. The four components employed in the Ugi reaction
are 2′,3′-isopropylidine-protected uridine-5′-aldehyde, 2,4-
dimethoxybenzylamine, an isoxazolecarboxylic acid, and the
convertible isonitrile N-(2-{[(tert-butyldimethylsilyl)oxy]meth-
yl}phenyl)carbonitrile. Following the Ugi reaction, treatment
with HCl in MeOH achieves deprotection of the isopropyl-
idene group and the N-benzyl group and conversion of the
isonitrile-derived amide (the Ugi product) into the corre-
sponding methyl ester. The procedure is amenable to auto-
mated multiparallel synthesis of novel compounds related to
the polyoxin and nikkomycin nucleoside-peptide antibiotics.
In our own recent studies,18 we reported a highly stereose-
lective, three-step synthesis of both natural (C5′-S) and unnatural
(C5′-R) diastereoisomers of uracil polyoxin C methyl ester. A
(2) Azuma, T.; Isono, K. J. Chem. Soc., Chem. Commun. 1977, 159–160.
(3) Azuma, T.; Isono, K. Chem. Pharm. Bull. 1977, 25, 3347–3353.
(4) Azuma, T.; Saita, T.; Isono, K. Chem. Pharm. Bull. 1977, 25, 1740–
1748.
(5) Cooper, A. B.; Desai, J.; Lovey, R. G.; Saksena, A. K.; Girijavallabhan,
V. M.; Ganguly, A. K.; Loebenberg, D.; Parmegiani, R.; Cacciapuoti, A. Bioorg.
Med. Chem. Lett. 1993, 3, 1079–1084.
(6) Isono, K.; Azuma, T.; Suzuki, S. Chem. Pharm. Bull. 1971, 19, 505–
513.
(7) Isono, K.; Suzuki, S.; Azuma, T. Agric. Biol. Chem. 1971, 35, 1986–
1989.
(8) Boehm, J. C.; Kingsbury, W. D. J. Org. Chem. 1986, 51, 2307–2314.
(9) Emmer, G.; Ryder, N. S.; Grassberger, M. A. J. Med. Chem. 1985, 28,
278–281.
(10) Fiandor, J.; Garcialopez, M. T.; Delasheras, F. G.; Mendezcastrillon,
P. P. Synthesis 1987, 978–981.
(11) Akita, H.; Uchida, K.; Chen, C. Y.; Kato, K. Chem. Pharm. Bull. 1998,
46, 1034–1038.
(12) Barrett, A. G. M.; Lebold, S. A. J. Org. Chem. 1990, 55, 3853–3857.
(13) Evina, C. M.; Guillerm, G. Tetrahedron Lett. 1996, 37, 163–166.
(14) Harding, K. E.; Southard, J. M. Tetrahedron: Asymmetry 2005, 16, 1845–
1854.
Polyoxins and nikkomycins (examples shown in Chart 1) are
nucleoside-peptide antibiotics that display biological activity
against fungal chitin synthase (CS) derived from Candida
albicans and/or Saccharomyces cereVisiae.1 Since chitin is
absent from mammals and plants, CSs are attractive targets for
inhibition in both fungi and insects. Literature-derived struc-
ture-activity relationships for the polyoxins, nikkomycins and
their synthetic analogues suggest several important structural
(15) Kato, K.; Chen, C. Y. Synthesis 1998, 10, 1527–1533.
(16) Moffatt, J. G.; Damodaran, N. P.; Jones, G. H. J. Am. Chem. Soc. 1971,
93, 3812–13.
(17) More, J. D.; Finney, N. S. Synlett 2003, 1307–1310.
(18) Plant, A.; Thompson, P.; Williams, D. M. J. Org. Chem. 2008, 73, 3714–
3724.
† Present address: Syngenta Crop Protection, Mu¨nchwilen AG, WST-810.3.38,
CH-4332 Stein, Switzerland.
‡ Present address: Piramal Healthcare, P.O. Box 521, Leeds Road, Hudder-
sfield HD1 9GA, UK.
(1) Cohen, E. Ann. ReV. Entomol. 1987, 32, 71–93.
4870 J. Org. Chem. 2009, 74, 4870–4873
10.1021/jo900244m CCC: $40.75 2009 American Chemical Society
Published on Web 05/20/2009